By Michael Bloom
Publication Date: 2026-05-19 12:30:00
Here are the biggest calls on Wall Street on Tuesday: Citigroup reiterates Micron Technology as buy Citi raised its price target on shares of Micron . “We raise our price target on Micron from $425 to $840 as we believe Micron is raising DRAM prices +40% in C2Q following peer Samsung’s +100% price hike in 1Q.” UBS upgrades Jazz Pharmaceuticals to buy from neutral UBS says it’s bullish on the company’s cancer drug, Ziihera. “We upgrade JAZZ to Buy from Neutral and raise our PT to $307 (from $188), driven by improved confidence in base business resilience and Ziihera’s commercial potential.” Morgan Stanley initiates X-Energy at overweight Morgan Stanley says the nuclear company is firing on all cylinders. ” XE i s a leading designer of advanced nuclear technology and manufacturer of advanced nuclear fuel.” Canaccord upgrades Progyny to buy from hold Canaccord says it sees revenue growth for the benefits management company. “We are upgrading Progyny to BUY with a $30 price target.” Morgan Stanley upgrades UMC to overweight from equal weight Morgan Stanley said in its upgrade of United Microelectronics that the semiconductor foundry company is compelling. “We cite attractive valuation and earnings upside from stronger mature node demand.” Barclays reiterates CrowdStrike as overweight Barclays raised its price target on CrowdStrike ahead of earnings in early June to $650 per share from $550. “We raise our PT to $650 using a 44x multiple on our FY31E FCF discounted back given…
